133 related articles for article (PubMed ID: 9769927)
1. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
3. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Dailloux M; Villemain P
Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Børsum T; Dannevig L; Størvold G; Melby K
Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
8. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
Cao W; Liu L; Tong MH
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ofloxacin against Chlamydia trachomatis.
Schachter J; Moncada JV
Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
[TBL] [Abstract][Full Text] [Related]
13. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
Bébéar CM; de Barbeyrac B; Pereyre S; Renaudin H; Clerc M; Bébéar C
Clin Microbiol Infect; 2008 Aug; 14(8):801-5. PubMed ID: 18727805
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of roxithromycin against Chlamydia trachomatis.
Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term.
Takahashi S; Hagiwara T; Shiga S; Takaoki Hirose T; Tsukamoto T
Chemotherapy; 2000; 46(6):402-7. PubMed ID: 11053906
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of ofloxacin against Chlamydia trachomatis.
Sambri V; Rumpianesi F; Xerri L; Cevenini R
J Chemother; 1989 Aug; 1(4):231-2. PubMed ID: 2809689
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Nagayama A; Nakao T; Taen H
Antimicrob Agents Chemother; 1988 Nov; 32(11):1735-7. PubMed ID: 3150916
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
Roblin PM; Hammerschlag MR
J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
